HepaRegenix GmbH


HepaRegeniX GmbH, Advisor: Dr. Markus Weissbach

Dr. Markus Weissbach

Dr. Markus Weissbach has over 30 years´ experience in the international pharmaceutical, biotechnology and Clinical Research Organization (CRO) industry. Formerly, Dr Weissbach was President of ICON plc Europe and CEO of Averion plc, two leading European CROs. He also served as Chief Medical Officer (CMO) for Europe at Novartis Vaccines and Diagnostics; Director Clinical Research and Development at Takeda Euro; R&D and International Medical Director Clinical Cardiology/Nephrology at Knoll AG – today Abbott, or AbbVie, respectively. Moreover, Dr. Weissbach worked as a consultant and advisory/supervisory board member for several companies over the last couple of years, including biotechs with activities in the area of liver diseases.